Skip to main content
. 2016 Feb 25;81(5):980–988. doi: 10.1111/bcp.12863

Figure 1.

Figure 1

Pharmacokinetics of GHB. (A) The data represent the plasma concentrations of GHB (mean and SD) after GHB administration at doses of 20 or 35 mg kg−1 in 16 subjects for each dose group. (B) The dashed lines in the semi‐log concentration–time plot represent the terminal linear elimination rate (λz). γ‐Hydroxybutyrate was administered at t = 0 min